Company profile

Kyverna Therapeutics, Inc. insider acquisitions

Company CIK 0001994702 · Reported insider acquisitions and filing context.

Company filings at SEC ↗
KYTX · Nasdaq

These are company listings. A transaction is linked to a particular security only when the filing provides enough information.

Company activity summary

By transaction date, as of October 23, 2026.

7 days30 days90 daysOverlapping periods · securities and currencies kept separate

No records are loaded for this 90-day transaction window. This does not establish that no transactions occurred.

Known purchase value sums available amounts for non-derivative purchases only. Missing amounts are excluded. “Currency not specified” does not establish that the amounts share a currency. These summaries use all matching loaded records, while the timeline below covers only the current page.

Transaction timeline

Who reported an acquisition, and when the transaction occurred.

Reported acquisitions by transaction dateEach row is a reporting owner. Select a marker to open its transaction details. Jointly reported transactions appear for each associated reporting owner, without dividing quantities or amounts.SEIDENBERG BETH CSEIDENBERG BETH CWestlake BioPartners Fund I, L.P.Westlake BioPartners Fund…Westlake BioPartners Opportunity GP I, LLCWestlake BioPartners Oppo…Westlake BioPartners Opportunity Fund I, L.P.Westlake BioPartners Oppo…Westlake BioPartners GP I, LLCWestlake BioPartners GP I…Walker Karen MarieWalker Karen MarieSEIDENBERG BETH C · December 18, 2025 · Purchase · Common StockWestlake BioPartners Fund I, L.P. · December 18, 2025 · Purchase · Common StockWestlake BioPartners Opportunity GP I, LLC · December 18, 2025 · Purchase · Common StockWestlake BioPartners Opportunity Fund I, L.P. · December 18, 2025 · Purchase · Common StockWestlake BioPartners GP I, LLC · December 18, 2025 · Purchase · Common StockWalker Karen Marie · December 15, 2025 · Exercise / conversion · Common StockDec 15, 2025Dec 18, 2025
PurchaseStock awardGift receivedExercise / conversionConversionOther acquisition

3 dated transactions · 6 of 6 reporting owners shown. Select one owner to focus the chart.

View timeline as a table
Transaction dateCompany / securityReporting ownersAcquisition type
Dec 18, 2025Kyverna Therapeutics, Inc.Common StockSEIDENBERG BETH CPurchase
Dec 18, 2025Kyverna Therapeutics, Inc.Common StockWestlake BioPartners Fund I, L.P. · Westlake BioPartners Opportunity GP I, LLC · Westlake BioPartners Opportunity Fund I, L.P. · Westlake BioPartners GP I, LLCPurchase
Dec 15, 2025Kyverna Therapeutics, Inc.Common StockWalker Karen MarieExercise / conversion

Only transactions on this page are shown. Date windows end on the latest transaction date in this sample. Joint filings may appear on more than one row. Sales are not included. Share-price charts use a separate data source.

Share price & reported acquisitions

Daily closing prices from a separate source. The date window above also filters prices; reporting-owner and transaction-type selections filter the markers.

Price history is not available

Market-price history is not connected yet.

KYTX · Currency not specified. A marker uses that day's closing price, not the reported transaction price. No price is substituted for a missing trading day.

Reported acquisitions

Filing-date filters apply to the list and timeline. The summary above uses transaction dates.

Reset
Reported insider acquisitions, ordered by filing date, newest first. Currency is shown only when reported.
Filed / transactedReporting ownersType / securityQuantityPrice / reference valueDetails
Trade: PurchaseCommon StockNon-derivative security · Code P133,3337.5Value: 999,997.5Currency not specifiedView ↗
Trade: Joint filing · amounts unallocatedPurchaseCommon StockNon-derivative security · Code P133,3337.5Value: 999,997.5Currency not specifiedView ↗
Trade:
Walker Karen MarieChief Technology Officer
Exercise / conversionCommon StockNon-derivative security · Code M23,9984.83Value: 115,910.34Currency not specifiedView ↗

Reporting owners are associated with a filing. Jointly reported amounts are not allocated to individual owners. Historical coverage is still being built. Read the methodology →